NASDAQ:FMED Fidelity Disruptive Medicine ETF (FMED) Price, Holdings, & News $24.74 -0.30 (-1.20%) (As of 05:26 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends About Fidelity Disruptive Medicine ETF (NASDAQ:FMED) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get FMED alerts:Sign Up Key Stats Today's Range$24.56▼$24.8550-Day Range$24.67▼$26.5852-Week Range$23.32▼$26.68Volume39,929 shsAverage Volume5,505 shsMarket Capitalization$51.95 millionAssets Under Management$53.23 millionDividend Yield0.44%Net Expense Ratio0.50%Aggregate RatingModerate Buy ETF OverviewThe Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.Read More… Fidelity Disruptive Medicine ETF ExpensesTypeFMEDTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.50%0.57%0.55%0.50%0.52%Other Expenses0.00%0.57%0.49%0.41%0.53%Total Expense0.50%0.73%0.71%0.64%0.71%Fee Waiver0.00%-0.74%-0.51%-0.31%-0.56%Net Expense0.50%0.60%0.61%0.57%0.59% Receive FMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fidelity Disruptive Medicine ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address FMED ETF News HeadlinesFidelity Disruptive Medicine ETF declares $0.112 dividendDecember 22, 2024 | seekingalpha.comSee More Headlines FMED ETF - Frequently Asked Questions How have FMED shares performed this year? Fidelity Disruptive Medicine ETF's stock was trading at $24.22 at the start of the year. Since then, FMED shares have increased by 2.1% and is now trading at $24.74. View the best growth stocks for 2024 here. How do I buy shares of Fidelity Disruptive Medicine ETF? Shares of FMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Fund Details IssuerFidelity Fund NameFidelity Disruptive Medicine ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:FMED Inception Date6/12/2023 Fund ManagerNiamh Brodie-Machura, Camille Carlstrom, Tim Codrington,Charlie Hebard,Michael Kim, Christopher Lee,William Shanley WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings63 Fund Statistics Assets Under Management$53.23 million Average Daily Volume$0.00 Discount/Premium-0.02% Administrator, Advisor and Custodian AdministratorFidelity Management & Research Company LLC AdvisorFidelity Management & Research Company LLC CustodianState Street Bank and Trust Company DistributorFidelity Distributors Company LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest10,900 shs Miscellaneous Outstanding Shares2,100,000Beta0.94 Creation Fee$200.00 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Top 10 FMED HoldingsBoston Scientific (NYSE:BSX)Holding Weight: 6.47%Fidelity Securities Lending Cash Central FundHolding Weight: 6.03%Insulet (NASDAQ:PODD)Holding Weight: 4.56%Intuitive Surgical (NASDAQ:ISRG)Holding Weight: 4.55%UnitedHealth Group (NYSE:UNH)Holding Weight: 4.06%Danaher (NYSE:DHR)Holding Weight: 3.75%Exact Sciences (NASDAQ:EXAS)Holding Weight: 3.40%argenx (NASDAQ:ARGX)Holding Weight: 3.34%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 3.05%Penumbra (NYSE:PEN)Holding Weight: 2.86%Full Holdings DetailsFMED Sector ExposureFMED Industry Exposure This page (NASDAQ:FMED) was last updated on 12/30/2024 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
